Skandinaviska Enskilda Banken Ab (Publ) Pacific Biosciences Of California, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $136,116 - $236,208	-22,800 Reduced 34.97%	42,400 $415,000
Q3 2023 Nov 09, 2023	SELL	$8.23 - $13.93 $110,282 - $186,662	-13,400 Reduced 17.05%	65,200 $544,000
Q2 2023 Aug 07, 2023	BUY	$9.97 - $14.05 $254,235 - $358,275	25,500 Added 48.02%	78,600 $1.05 Million
Q1 2023 May 11, 2023	BUY	$7.94 - $12.02 $421,614 - $638,262	53,100 New	53,100 $615,000
Q1 2022 May 11, 2022	SELL	$8.43 - $20.9 $206,577 - $512,154	-24,505 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$22.3 - $36.02 $546,461 - $882,670	24,505 New	24,505 $857,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.